Interviews Interviews Expert talks and scientific presentations by local and international clinicians and scientists. Published: Dec 08, 2018

ApoE & Alzheimer’s disease: can genetic testing inform clinical practice?

Using a clinical precision medicine strategy that incorporates ApoE4 carrier status may provide a highly targeted approach to Alzheimer’s disease prevention.

Dr Isaacson has received honoraria/consultation fees from Neurotrack.

Learn more

Dementia Genetics omega-3-fatty acids ApoE Prevention Alzheimer’s disease ApoE4 generation 2 generation 1 REVEAL FINGER